Johnson & Johnson lost a gamble in going to trial over Oklahoma's claims it helped create the opioid crisis as a district court judge issued a $572m judgement against the company to fund a one-year abatement plan. The sum is $300m more than Purdue agreed to pay in its settlement with the state but a fraction of the $12.8bn the state estimated it would cost to ameliorate the crisis over a 20-year period.
Oklahoma alleged that J&J and its Janssen Pharmaceuticals Inc. unit engaged in a false, misleading, and deceptive marketing campaign designed to convince Oklahoma doctors, patients, and the public at...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?